Sources tell Bloomberg that Johnson & Johnson (JNJ -0.1%) has agreed to pay more than $1B to...

|About: Johnson & Johnson (JNJ)|By:, SA News Editor

Sources tell Bloomberg that Johnson & Johnson (JNJ -0.1%) has agreed to pay more than $1B to settle a civil probe by the U.S. attorney's office in Philadelphia into the marketing of Risperdal.